Veolia水务技术与方案

制药用水的药典测试

Compendial testing encompasses the comprehensive analytical testing needed to verify the quality and safety of pharmaceutical  and biopharmaceutical materials. While many tests focus on finished drug products, water is perhaps the most critical component, serving as a foundational raw material, ingredient, and solvent in the processing, formulation, and manufacture of pharmaceutical products, active pharmaceutical ingredients (APIs), and analytical reagents.

Whether producing water for pharmaceutical purposes such as Water for Injection (WFI), Purified Water (PW), or any water used in production, all must comply with precise specifications outlined in the official compendia to meet the quality standards enforced by regulatory bodies worldwide and guarantee product safety and efficacy. To navigate these rigorous requirements, manufacturers rely on USP <1231> "Water for Pharmaceutical Purposes", an informational chapter that provides essential guidance on designing, validating, and monitoring bulk water systems to maintain strict microbial and chemical control.

制药用水的药典测试

Compendial testing encompasses the comprehensive analytical testing needed to verify the quality and safety of pharmaceutical  and biopharmaceutical materials. While many tests focus on finished drug products, water is perhaps the most critical component, serving as a foundational raw material, ingredient, and solvent in the processing, formulation, and manufacture of pharmaceutical products, active pharmaceutical ingredients (APIs), and analytical reagents.

Whether producing water for pharmaceutical purposes such as Water for Injection (WFI), Purified Water (PW), or any water used in production, all must comply with precise specifications outlined in the official compendia to meet the quality standards enforced by regulatory bodies worldwide and guarantee product safety and efficacy. To navigate these rigorous requirements, manufacturers rely on USP <1231> "Water for Pharmaceutical Purposes", an informational chapter that provides essential guidance on designing, validating, and monitoring bulk water systems to maintain strict microbial and chemical control.

Understanding pharmaceutical-grade water standards

Pharmaceutical-grade water comes in several distinct grades, each with specific quality attributes and permitted uses. From WFI, Purified Water, or water used in production, these waters must meet requirements defined by the United States Pharmacopeia (USP), European Pharmacopoeia (EP/Ph. Eur.), and Japanese Pharmacopoeia (JP). To guarantee purity and safety, compendial monographs mandate critical tests for waters, particularly Total Organic Carbon (TOC) (USP <643>), Water Conductivity (USP <645>), Bacterial Endotoxins and Microbial Enumeration/Microbial Limits. While offline compendial testing in the laboratory plays a crucial role, manufacturers no longer rely solely on this data for decision making and process control. Instead, real-time, online monitoring of water purity provides continuous in-process data to support the industry’s drive toward Process Analytical Technology (PAT).

Why comprehensive water quality monitoring matters

Effective water monitoring programs provide comprehensive compendial testing and analysis to detect contamination and verify system performance, all while maintaining compliance for reporting to regulatory authorities. Unlike other pharmaceutical ingredients, pharmaceutical waters are generally produced by continuous processes and used in manufacturing soon after generation, likely before traditional, definitive microbial test results are available. Rigorous water system validation and quantitative monitoring against established alert and action levels provide early indication of system control. These early indicators are critical for detecting an approaching quality shift.

Whether you're validating pharmaceutical-grade water system operations, conducting routine quality control testing against official compendia specifications, or troubleshooting process deviations, accurate and reliable analytical methods are the foundation for protecting products, processes, and above all, patients. By adhering to rigorous standards for water for pharmaceutical purposes, including those outlined in USP, EP, and JP pharmacopeias, your facility ensures that every batch meets the stringent requirements necessary for safe and effective drug manufacturing.

A comprehensive and quantitative understanding of your water system is at the heart of quality monitoring for life sciences.  In regulated industries where patient safety is paramount, robust water quality assurance programs are essential for sustainable operations and regulatory success. From formulation and manufacturing to cleaning and sterilization, water quality directly impacts product integrity, process reliability, and patient safety.

Quantitative, repeatable and documented

法律合规

药典合规性、数据完整性和审计就绪

FDA等监管机构以及USP、EP、JP等药典规定,制药用水必须满足严格的纯度标准和质量规范才能使用。为了保持经过验证的受控状态,工厂必须持续监控核心质量属性。这需要对总有机碳(TOC)和水电导率进行全面测试,以检测有机和离子杂质。此外,微生物定量计数可确保系统维持微生物控制,而细菌内毒素检测(BET)则是WFI等关键级别用水需要满足的严格的监管要求。

满足这些规范只是第一步,合规性的证明还有赖于数据完整性。保持数据完整性是实现法律合规和审计就绪的基础。通过确保收集的所有数据都符合ALCOA+(可归因、易读、同步、原始和准确)原则和21 CFR Part 11的要求,可以为所有水质测量提供完整、防篡改的审计追踪。

工厂通过PAT集成实现数据采集的自动化,从而消除了手动转录错误,并确保持续的审计跟踪。通过将自动化文档与全面的趋势分析相结合,制造商能够快速响应监管查询,展示稳健可靠的系统控制,并提供持续符合药典要求和关键水质参数的证据。

合规性 数据可靠性

 

 

 

cGMP & Quality by Design

前瞻性的设施水系统设计、监测和控制

现行的药品生产质量管理规范(cGMP)为水系统的设计、运行和监测确立了一套基线要求。根据cGMP,工厂必须根据水的预期用途制定并监测适当的规格。然而,正如FDA明确指出的那样,“仅靠检测不足以确保质量。”相反,质量必须融入设计和制造过程的每一个环节。

现代cGMP还鼓励采取超越最低合规要求和传统测试的主动式方法。cGMP中的“C”代表“当前”,要求公司使用最新的技术和系统来推动持续改进。这意味着要认识到,按照今天的标准,较旧的系统或监控方法可能已无法充分适用。例如,USP <1223>和EP第 5.1.6章等监管指南概述了评估、选择和鉴定替代微生物学方法的步骤。传统培养方法可能需要48到72小时(甚至更长时间)才能产生检测结果,而采用先进的仪器方法和快速微生物方法(RMM)可缩短获得检测结果的周期。这种更快的微生物污染检测有助于更及时地采取纠正措施并改进工艺控制。

通过实施持续监控系统、自动化控制和数据分析,工厂能够建立并跟踪经过验证的警戒限和行动限。根据FDA的指导原则,这些限值必须基于验证数据来设定,并应设置得足够低,以指示偏离正常操作条件的显著变化。针对这些限值的持续的数据趋势分析可作为早期预警系统,在水系统失控之前发出信号,提醒质量可能即将发生变化。通过采用这些前瞻性技术,工厂能够适应不断变化的监管环境,从而彰显其对质量和患者安全的承诺,这与现代药品制造原则是一致的。

资源:

污染控制

污染控制和杂质监测

在患者安全至关重要的受监管行业中,稳健可靠的水质保证计划对于可持续运营和监管合规性至关重要。从配方和制造到清洁和灭菌,水质会直接影响产品完整性、工艺可靠性和患者安全。

水系统具有内在的脆弱性,难以抵御可能干扰系统运行的外源性(外部)和内源性(内部)污染的影响。虽然给水会带来初始的有机物、无机物和颗粒物风险,但分配系统本身也构成了持续存在的薄弱环节。最显著的微生物威胁是生物膜的形成。这种附着在管道、阀门和水箱上的适应性微生物群落会不断向水流中释放游离细菌。在注射用水(WFI)等关键级别用水中,这些生物膜还会释放细菌内毒素,如果缺乏妥善的控制和检测,则会对患者安全构成严重的风险。

即使是痕量水平的这些污染物也会在整个制造过程中产生连锁效应。为了降低这种风险,持续的在线监测是必不可少的。作为有机化合物的关键间接测量手段,总有机碳(TOC)测试可检测从源水污染物到溶出有机物和生物膜副产物等各种物质。与此同时,电导率监测可检测外来的无机离子,从而立即给出化学纯度的测量值。

如果没有定量微生物计数和持续的化学监测,污染很容易被漏检。通过积极监测这些杂质,工厂可以防止微小的工艺偏差演变成代价高昂的生产延迟、设备损坏、产品召回或监管违规。

资源和案例研究 清洁验证

 

 

 

 

 

 

通过简化的药典水监测解决方案降低风险和工作量

Sievers系列仪器是一个全面的产品组合,涵盖了药典水质检测的各项要求。Sievers仪器以开创性的TOC和电导率监测技术起步,现已发展成为关键内毒素和生物负载检测的先进解决方案。我们的解决方案旨在验证关键质量属性,并以精确可靠的性能满足严格的USP、EP和JP药典标准。

通过选择拥有全面产品组合的仪器制造商,工厂可以获得值得信赖的单一水质检测来源,从而显著降低供应商管理的复杂性。通过支持严格的验证和鉴定流程(IQ、OQ和PQ),我们的专业知识确保了测试参数持续合规。我们的专家团队对于复杂水质检测领域有深入的了解,可提供一体化的支持和服务。通过选择Sievers产品来满足您的药典检测需求,您获得的不仅仅是仪器,而是一支专家团队对您的制药用水质量管理的支持,从而使您的系统始终保持经过验证的受控状态。

Real-Time Testing

快速获得检测结果使连续的工艺控制成为现实

实时放行检测(RTRT)对工厂具有变革性意义,并已成为新的行业标准。即时数据使制造商能够更快地发现趋势,并获得即时的系统性能反馈。

通过利用在线仪器检测TOC和电导率等关键属性,工厂可以生成连续的过程数据。这种即时数据充当早期预警系统,使系统工程师能够发现趋势,并对警戒限和行动限作出响应,以防止潜在的超标(OOS)事件发生。这种水平的控制可以大大减少浪费、延误和风险。

在清洁验证中,传统的清洁程序方法由于其手动操作的性质而经常造成运行效率低下。这会导致设备放行延迟并影响生产计划。制造商现在正在利用实时监测技术和集成水质检测解决方案来简化清洁验证方案,同时确保法律合规。

过程分析技术是药典水质检测的未来

现代过程分析技术(PAT)超越了使用点水检测的范畴,已涵盖集成数据管理、自动化过程控制和智能水系统监控。向连续在线检测的转变会产生大量有价值的过程数据。在药典水质检测中实施PAT可以彻底改变制造商实时记录、监测和管理制药用水质量的方式。

PAT集成与实时水质监测和自动化过程控制系统相结合,使制造商能够实现水系统持续监控和合规性管理的优化和自动化。这种方法有助于保持最高标准的制药用水质量和患者安全。此外,PAT驱动的策略符合监管部门对过程控制的期望,为水系统管理提供了无可辩驳的、数据驱动的洞察。

资源:

Robust, reliable and accurate

 

 A comprehensive and quantitative understanding of your water system is at the heart of quality assurance

Life science manufacturers seek simplified and reliable analytical testing while maintaining compliance. As a world-leading provider of analytical instruments, Veolia transforms complex measurements into simple and reliable processes with the Sievers portfolio.

Sievers instruments measure TOC, conductivity, endotoxins, and bioburden to support your process monitoring and cleaning validation as part of compendial water testing compliance. By enabling real-time testing, automation, process control, and risk mitigation, you can drive efficiency without compromising accuracy or compliance.

Facilities worldwide trust Sievers Instruments, software, consumables, services and expertise to make critical testing easier, faster, and compliant—so you can focus on what matters most: your production.

TOC, Conductivity and Chemical Testing

Total organic carbon (TOC) analysis serves as a fundamental indirect measurement of organic molecules present in water systems, as mandated by compendial testing outlined in USP <643>. This non-specific analysis quantifies organic compounds through CO2 formation. These organic contaminants can interfere with pharmaceutical processes and compromise product purity. More importantly, carbon-based molecules act as a food source for microorganisms, making TOC control a vital step in mitigating microbial growth and reducing contamination risk.

Conductivity testing quantifies a water sample’s electrical conductivity to assess dissolved ionic impurities. Using a staged testing process of increasing complexity, this temperature-specific measurement is detailed in USP <645>. The shift to TOC and conductivity testing served as a reliable and convenient alternative to older wet chemistry methods, crucially providing the immediate, continuous feedback required for process control and quality assurance.

 

Sievers m500

Sievers M500在线TOC分析仪

Features simultaneous TOC & conductivity, automated calibration & validation, 21 CFR Part 11 & FDA data integrity  

Sievers M9实验室分析仪

Sievers M9实验室分析仪

Simultaneous TOC and conductivity for pharmaceutical water, WFI, cleaning validation, diagnostics ...

 

Sievers M9在线分析仪

Sievers M9在线TOC分析仪

Real-time monitoring for pharmaceutical water systems and water for injection, with autoreagent and more...

Sievers M9便携式TOC分析仪

Sievers M9便携式TOC分析仪

At-line monitoring of pharmaceutical water systems, at-line cleaning validation, simultaneous TOC and conductivity 

 
Rapid Microbial Detection - Bacterial Endotoxin and Bioburden Testing

Bacterial endotoxin testing (BET) detects lipopolysaccharides shed by gram-negative bacteria. Even in trace amounts, these pyrogens can cause dangerous, severe reactions in patients, making endotoxin testing a critical safety parameter in pharmaceutical water systems. Traditional endotoxin assays require approximately 2-3 hours for setup and final results, positioning this test as higher risk than TOC or conductivity monitoring due to longer result times and increased contamination threat.

Today, endotoxin testing has evolved significantly. Innovative technologies now provide the simplicity, speed, and robustness necessary to reduce risks, supporting real-time decision-making while maintaining the accuracy required for patient safety compliance.

Bioburden testing measures the total number of viable organisms present in water systems, ensuring systems aren't harboring potentially harmful bacteria or other microbes that could continuously shed contamination into the water stream and contaminate products. Traditional plate-based culture methods represent a high risk category, requiring 48 to 72 hours (and sometimes up to 5 to 7 days) for microbial growth and enumeration. Because pharmaceutical waters are produced continuously and used in manufacturing soon after generation, the water is likely used well before these definitive test results are available. This extended delay prevents proactive management, potentially allowing a contamination event to persist and spread.

With the push for quantitative data suitable for real-time process control, recent advances in biological monitoring prioritize a drastic reduction in time-to-results while maintaining compendial accuracy and reliability.

 

Sievers Eclipse

Sievers Eclipse细菌内毒素检测仪

The innovative Sievers Eclipse automated endotoxin detection platform decreases assay setup time by up to 85% and reduces Limulus Amebocyte Lysate (LAL) reagent use by up to 90%

Sievers Soleil

Sievers Soleil快速微生物检测仪

What if you could get your bioburden results in 45 minutes of less? when you're waiting days for bioburden results, there's a lot at risk. But with rapid microbial testing ...